Qualigen Therapeutics, Inc.
Q4 2020 13F Holders
Symbol
QLGN
CUSIP
74754R103
Type
Equity
Class
COM
Num filers
30
Total reported value, excl. options
$3.58 M
Compare 2020 Q4 to
2022 Q3
2022 Q2
2022 Q1
2021 Q4
2021 Q3
2021 Q2
2021 Q1
2020 Q3
2020 Q2
Manager
Report Date
Value ($000)
Shares
Option Type